- Home
- CCG vs APLT Comparison
CCG vs APLT Comparison
Compare CCG & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCG
- APLT
- Stock Information
- Founded
- CCG 2014
- APLT 2016
- Country
- CCG China
- APLT United States
- Employees
- CCG N/A
- APLT N/A
- Industry
- CCG
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- CCG
- APLT Health Care
- Exchange
- CCG Nasdaq
- APLT Nasdaq
- Market Cap
- CCG 75.1M
- APLT 37.5M
- IPO Year
- CCG N/A
- APLT 2019
- Fundamental
- Price
- CCG $0.83
- APLT $0.41
- Analyst Decision
- CCG
- APLT Buy
- Analyst Count
- CCG 0
- APLT 7
- Target Price
- CCG N/A
- APLT $6.10
- AVG Volume (30 Days)
- CCG 252.7K
- APLT 1.9M
- Earning Date
- CCG 05-29-2025
- APLT 05-20-2025
- Dividend Yield
- CCG N/A
- APLT N/A
- EPS Growth
- CCG N/A
- APLT N/A
- EPS
- CCG N/A
- APLT N/A
- Revenue
- CCG $475,831,129.00
- APLT $455,000.00
- Revenue This Year
- CCG N/A
- APLT $1,768.13
- Revenue Next Year
- CCG $7.06
- APLT $361.28
- P/E Ratio
- CCG N/A
- APLT N/A
- Revenue Growth
- CCG 5.20
- APLT N/A
- 52 Week Low
- CCG $0.56
- APLT $0.30
- 52 Week High
- CCG $2.39
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- CCG 44.58
- APLT 48.67
- Support Level
- CCG $0.81
- APLT $0.39
- Resistance Level
- CCG $0.88
- APLT $0.49
- Average True Range (ATR)
- CCG 0.08
- APLT 0.04
- MACD
- CCG 0.00
- APLT 0.01
- Stochastic Oscillator
- CCG 14.18
- APLT 55.40
About CCG Cheche Group Inc.
Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services and other services in China.. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.